Clinical trial
Study Evaluating SKI-606 Administered to Healthy Subjects
NCT00406406 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00406406 |
|---|---|
| Title | Study Evaluating SKI-606 Administered to Healthy Subjects |
| Official title | Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SKI-606 Administered Orally to Healthy Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SKI-606 |
| Start date | Nov 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 5, 2007 |
| Countries | Netherlands |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: